SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-016140
Filing Date
2021-08-09
Accepted
2021-08-09 08:33:32
Documents
21
Period of Report
2021-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20210809.htm   iXBRL 8-K 40526
2 EX-4.1 supplementalindentureexe.htm EX-4.1 13752
3 EX-99.1 ex991_125notereopenerexten.htm EX-99.1 14160
7 image_0a.jpg GRAPHIC 62743
8 GRAPHIC supplementalindentureexe001.jpg GRAPHIC 248622
9 GRAPHIC supplementalindentureexe002.jpg GRAPHIC 287458
10 GRAPHIC supplementalindentureexe003.jpg GRAPHIC 316677
11 GRAPHIC supplementalindentureexe004.jpg GRAPHIC 124139
12 GRAPHIC supplementalindentureexe005.jpg GRAPHIC 52449
13 GRAPHIC supplementalindentureexe006.jpg GRAPHIC 46297
  Complete submission text file 0001628280-21-016140.txt   1792236

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20210809.xsd EX-101.SCH 2154
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20210809_lab.xml EX-101.LAB 25268
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20210809_pre.xml EX-101.PRE 13287
14 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20210809_htm.xml XML 11735
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211154770
SIC: 2834 Pharmaceutical Preparations